fbpx
Connect with us

NEWS

Mym Nutraceuticals Inc (OTCMKTS:MYMMF) Teams Up With Dutch Passion; Pulls Off Automatic Securities Disposition Plan

Published

on

Mym Nutraceuticals Inc (OTCMKTS:MYMMF) recently signed an agreement for two years with Dutch Passion, an Amsterdam-based company. As per the agreement MYM will produce and distribute seed genetics and products of Dutch Passion brand in Australia. Also, the company recently pulled off its automatic securities disposition plan (ADSP).

MYM seeks relief from ADSP plan

The plan was launched on December 29, 2017. According to the company, it shelved the plan as it needs to fulfill certain insider filing requirements related to ASDP associated with the Process of Exemptive Relief Applications in Multiple Jurisdictions, the British Columbia Securities Commission, and the Ontario Securities Commission. That is why the company recently sought relief from the plan. Although the relief was given to MYM on May 2 this year, it is yet to complete the formalities of an administrative agreement with an independent broker dealing in securities. Unless the company fulfills this criterion it cannot start the plan. As of now, none of the officers or the Directors has sold their shares under ADSP.

MYM believes its association with Dutch Passion to prove valuable

The CEO of MYM, Rob Gietl while discussing the decision of his company to enter into an agreement with the second oldest Cannabis seed company in the Europe said,” We are thrilled to be working with Dutch Passion in Australia. With over 30 years-experiences in the development and distribution of cannabis seeds, they are considered to be world leaders. The Dutch Passion portfolio of seeds will prove to be a very valuable asset to the shareholders of MYM.”

Dutch Passion was established in 1987 and hence has an experience of more than three decades as the seed genetics innovator. Over the years, the company has developed proprietary genetics and now also has an international cannabis genetics seed collection that dates back to the 1970s. The company has also won over 50 Cannabis Cups for MYM’s easy-to-grow, high THC varieties. In the 1990s the Danish company made the invention of feminized cannabis seeds and recently was the pioneer behind the success of high-THC-auto-flowering seeds of marijuana.

According to the CEO of Dutch Passion, Eric Siereveld, they choose MYM out of the multiple options because the company has a strong network in the global marijuana industry.

NEWS

Generex Biotechnology Corporation (OTCMKTS:GNBT) Launches An Integrated Health Management Platform

Published

on

In a new wake of events, Generex Biotechnology Corporation (OTCMKTS:GNBT) has introduced a platform, which primarily deals with in-depth patient health management services. NuGenerex Medical Marketing (NMM) is a significant project and will act as the company’s sales and marketing backbone support. Some of the areas it will handle include patient identification, acquisition, and onboarding. Its establishment comes at a time when hundreds of pharmaceuticals businesses are seeking measures to accelerate their growth and expansion.

Generex is seeking entry into the U.S market and the reason it has embraced a multi-channel acquisition strategy. The strategy has been running for several months the main target being assets and organizations, which offer a series of services.

NMM will provide national marketing and customer service capabilities

Generex will benefit in a million ways from the new establishment; thanks to its capabilities. NMM plans to roll out an extensive pharmacy backbone, which will in return offer a nationwide footprint. It will have an integration with Customer Relationship Management (CRM) dashboard for Generex. Through a dedicated call-center, the integration will support the company’s ongoing patient support services and particularly the chronic care management.

In addition, NMM will offer compliant direct-to-patient outreach services, which are fully compliant with the market needs. An accomplished team, which has deep experience in pharmaceutical and medical device sales will support the new move. The team is trained in HIPAA, FTC and it has full exposure of the FDA rules. Thus it will ensure adherence to processes and procedures in the delivery of medical services.

The realization of a vision for a new healthcare enterprise

For the last two years, Generex has worked diligently to enhance the delivery of its services. Its emphasis is on unlocking new platforms, which will offer end-to-end treatment and services solutions. This far, the company is happy with its achievements according to the Chief Executive Officer Joseph Moscato.

He says, “We are delighted to launch NuGenerex Medical Marketing as another step in our overall corporate strategy to provide end-to-end solutions that optimize patient health outcomes.”

Meanwhile, the company has vowed to continue closing on the acquisition of additional operating assets. Its expectation is to meet the initial listing requirements one of them being a lucrative enterprise with a presence in another 23 states.

Continue Reading

NEWS

Earth Science Tech Inc. (OTCMKTS:ETST) Has A New Update Regarding Its Cannabidiol Patents

Published

on

Earth Science Tech Inc. (OTCMKTS:ETST) has shared a new update regarding its cannabidiol (“CBD”) patents. The biotech company says that it is ready to launch its two CBD-based nutraceutical formulas. They include a neuron protector and a breast protector. However, there is so much that is yet to hit the public domain as explained by ETST president and CEO Nickolas Tabraue.

Tabraue outlines, “We will provide more details on the progress of these formulas in the near future.” At the same time, the company has also promised to share the way forward regarding its first CBD-based pharmaceutical product.

The use of CBD and will open the doors for the research

For a very long time, the cannabis industry was for the most successful entrepreneurs in history. However, the market is now open to people from all walks of life thanks to the massive expansion. Thus the need for accelerated research activities. Tabraue affirms that research will result in the development of a revolutionary CDB-based pharmaceutical drug. This will give Earth Science Tech an upper hand in spreading its presence globally.

The formulas will undergo an in vitro testing to establish their biological activities. TransBiotech will carry out the testing, which will compare the level of protection of the hemp oil provided by ETST. The comparison will be against the company’s hemp oil with other natural ingredients. Any positive results will increase its current recognition as a world leader in the CBD space.

Earth Science Tech, Inc. offers the highest quality high-grade full spectrum cannabinoid oil

The company’s Chief Science Officer Dr. Michel Aubé claims that they have a much deeper understanding of cannabinoids compared to their competitors. Besides, the company has received an endorsement verifying that CBD is not addictive. Apparently, CBD was previously under schedule 1 drug classification before its recent shift by U.S. Drug Enforcement Agency (DEA). Nonetheless, there are those CBD products, which DEA has maintained that they are controlled substances. Hence they retain their status in the Schedule 1 list

ETST’s core activities include the formulation, marketing, and distribution of CBD oil. It owns four subsidiaries, which are quickly expanding their operations in the pharmaceutical sectors.

Continue Reading

NEWS

ELEV8 BRANDS (OTCMKTS:VATE) Expands Its Business Operations

Published

on

ELEV8 BRANDS (OTCMKTS:VATE) focuses in the manufacture of hemp and CBD-related products. These include the CBD Lotions, hemp Cold Brew, CBD salve, hemp tea, hemp coffee as well as the CBD Tinctures. Most of these quality products are useful in the health and wellness markets. This business guru has acquired the newly formed One Utopia, LLC.

The state of affairs

ELEV8 BRANDS outlines that it has settled on One Utopia, LLC as the new name for the brick and mortar locations that will focus on the sale of products that 02 Breathe sells currently. Some of these products include massage products, salt lamps, essential oils and above all CBD products.

It was recently that this company signed a one-year lease for a store location in Cocoa Village at 409 Delannoy Avenue. Cocoa village is a historical village where activities such as dining, shopping and entertainment take place.

One Utopia has acquired a brand-new mobile coffee trailer. Some of the products this company will manufacture include mushroom coffee, matcha lattes, hemp coffee drinks, tea and other beverages. Most of them come with a wide range of benefits. Elev8 Brands states that the new mobile coffee trailer is a great addition. Eventually, it admits it that it has never enjoyed such impressive presence before.

Medico’s perspective

The CEO Ryan Medico opined, “We have a lot of moving parts right now and are very excited about the growth. Getting product delivered up to Amazon facilities in Canada and finishing up our audit is our highest priority.”

The official advocates for the capitalization of the expansion. To achieve the set objective, the company has brought on board a full time National Sales Manager. The new official will take care of account management. It also wants to pay a great focus on the pursuance of trade shows. It has enough personnel to help it accomplish this objective.

ELEV8 BRANDS says it will do everything possible to ensure that it experiences exponential growth over the coming months. There are positions that will compel the company to employ persons with extensive sales background.

Continue Reading

Trending Stories